Publication Details

Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease.

Hudson MM, Weinstein HJ, Donaldson SS, Greenwald C, Kun L, Tarbell NJ, Humphrey WA, Rupp C, Marina NM, Wilimas J. J Clin Oncol. 1993; 11 (6): 1080-4

We report an unexpectedly high incidence of hypersensitivity to etoposide among 45 patients with newly diagnosed Hodgkin's disease treated with vinblastine, etoposide, prednisone, and doxorubicin (VEPA) plus radiation.

PubMedID: 8501494